Moore Capital Management’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-45,000	Closed	-$2.26M	–	239
2017 Q3	$2.26M	Buy	+45,000	New	+$2.26M	0.04%	137